http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3233054-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50693592692bfb81e69ac669f85d738c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33d89a158e7efe65a9dca77d6581d564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94fb8551b607dc2bcc8d7a114b791914
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ef96ff5a64237dc1a1db5c831f5c05f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb14b6af9e03059d19a4c420e8ac7d05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74197a3f69a183e362b3951abd0be514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e09ea4b774514f8386c61472baf9543f
publicationDate 2017-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3233054-A1
titleOfInvention Formulations of a pi3k/mtor-inhibitor for intravenous administration
abstract The present invention relates to a pharmaceutical aqueous formulation comprising -(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.
priorityDate 2014-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228164315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226419129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22989253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121415678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227100450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID258391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID316813012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44516953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428

Total number of triples: 51.